A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...
Advanced therapies have helped boost the 5-year survival rates for some cancers above 90%. But many other forms remain difficult to treat, and 'there aren't many good drugs.' ...
A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...
A breakthrough therapy is driving aggressive leukaemia into remission. Here’s what the headlines don’t tell you about life ...
Researchers from the Keck School of Medicine of USC have developed a new type of chimeric antigen receptor (CAR) T cell that ...
CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...
A laboratory study out of Roswell Park Comprehensive Cancer Center outlines a new way to boost the effectiveness of chimeric ...
CAR T cell immunotherapy, which uses a patient’s own modified immune cells to find and destroy cancer cells, can produce dramatic results when treating blood cancers, such as lymphoma and leukemia, ...
CAR T cell immunotherapy, which uses a patient's own modified immune cells to find and destroy cancer cells, can produce dramatic results when treating blood cancers like lymphoma and leukemia and ...
Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback